There is an urgent need to prevent the proliferation of counterfeit and substandard pharmaceuticals
Enabling the use of generics, supporting local businesses and setting up a state pharmaceutical company would boost healthcare
Donald Trump’s funding freeze underlines that South Africa needs to prioritise the development of its pharmaceutical manufacturing sector
On a month-on-month basis retail trade sales decreased for the fourth consecutive month showing that consumers are still cash-strapped
The next three to five years will require the continent to ensure there is sustainable business beyond Covid-19.
Document details contingency planning if Britain leaves the European Union in March with no transition deal
Male starlings sang less and were more aggressive towards females that had been given small doses of the antidepressant Fluoxetine
The battle to eliminate fake pharmaceutical products is being stepped up
Pharmaceutical companies say that delayed drug registrations by the Medicines Control Council may have played a role in stock outs.
Will the world act now to be ready for the next big outbreak?
There is a big move afoot to alert SADC members to the concessions on intellectual property rights that they can take advantage of.
A promising new TB drug is now on the market but doctors say it’s been priced out of reach.
The department of trade and industry has yet to finalise patent reforms, raising questions that cheaper medication could be blocked intentionally.
There is widespread support for drastic change to patent laws when it comes to pharmaceuticals, but the results could be disastrous.
M&G readers comment on comparisons of Nelson Mandela, Thabo Mbeki and Jacob Zuma, and say we need cool heads when it comes to pharmaceutical drugs.
We should welcome the arrival of US-style political lobbying in South Africa, done in public rather than in private.
Health minister Aaron Motsoaledi is livid about a pharmaceutical company campaign he says will restrict access to crucial drugs.
The pharmaceutical company Adcock’s biggest shareholder PIC says it has not yet made a decision about whether to support the takeover of CFR.
Some have lauded the draft policy, saying it could make medication cheaper, but others say it is "unimpressive" and "almost contradictory".
A draft intellectual property policy has been lauded by rights groups who say its repercussions on drug patents could make medicines more affordable.
